Page last updated: 2024-11-02

pamidronate and Focal Segmental Glomerulosclerosis

pamidronate has been researched along with Focal Segmental Glomerulosclerosis in 10 studies

Research Excerpts

ExcerptRelevanceReference
"The American Society of Clinical Oncology recommends bisphosphonate use, such as intravenous pamidronate, for women with breast cancer who have radiographic evidence of bone destruction."8.85Pamidronate-induced kidney injury in a patient with metastatic breast cancer. ( Nagahama, M; Sica, DA, 2009)
"Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glomerular epithelial cells."5.33Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. ( Assmann, KK; Dijkman, HB; Smeets, B; Steenbergen, EJ; van Kuppevelt, TH; Verrijp, KC; Weening, JJ; Wetzels, JF, 2006)
"Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases."5.31Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. ( Appel, GB; D'Agati, VD; Dratch, AD; Fenves, AZ; Fine, PL; Jagannath, S; Kuhn, JA; Loon, NR; Markowitz, GS, 2001)
"The American Society of Clinical Oncology recommends bisphosphonate use, such as intravenous pamidronate, for women with breast cancer who have radiographic evidence of bone destruction."4.85Pamidronate-induced kidney injury in a patient with metastatic breast cancer. ( Nagahama, M; Sica, DA, 2009)
"Pamidronate has been mainly associated with collapsing focal segmental glomerulosclerosis."3.72Podocyte injury associated glomerulopathies induced by pamidronate. ( Abulezz, SR; Barri, YM; Bonsib, SM; Munshi, NC; Sukumalchantra, S; Walker, PD; Wallach, J, 2004)
"Collapsing focal segmental glomerulosclerosis is well described in its idiopathic form, mostly seen in young African American patients, and in association with HIV virus."2.45[Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review]. ( Jotterand, V; Martin, PY; Moll, S; Saudan, P, 2009)
" Patterns of nephrotoxicity described with these agents include toxic acute tubular necrosis and collapsing focal segmental glomerulosclerosis, respectively."2.44Bisphosphonate nephrotoxicity. ( Markowitz, GS; Perazella, MA, 2008)
"Collapsing focal segmental glomerulosclerosis (cFSGS) is characterized by hyperplasia of glomerular epithelial cells."1.33Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. ( Assmann, KK; Dijkman, HB; Smeets, B; Steenbergen, EJ; van Kuppevelt, TH; Verrijp, KC; Weening, JJ; Wetzels, JF, 2006)
"Pamidronate, which is a member of the class of bisphosphonates, is widely used in the treatment of hypercalcemia of malignancy and osteolytic metastases."1.31Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. ( Appel, GB; D'Agati, VD; Dratch, AD; Fenves, AZ; Fine, PL; Jagannath, S; Kuhn, JA; Loon, NR; Markowitz, GS, 2001)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (90.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perazella, MA1
Markowitz, GS3
Jotterand, V1
Moll, S1
Martin, PY1
Saudan, P1
Nagahama, M1
Sica, DA1
Yoshizawa, H1
Akimoto, T1
Nishino, K1
Inoue, M1
Ito, C1
Takeda, S1
Kotoda, A1
Tamba, K1
Yumura, W1
Muto, S1
Ueda, Y1
Kusano, E1
Barri, YM1
Munshi, NC1
Sukumalchantra, S1
Abulezz, SR1
Bonsib, SM1
Wallach, J1
Walker, PD1
Kunin, M1
Kopolovic, J1
Avigdor, A1
Holtzman, EJ1
Nasr, SH1
Preddie, DC1
Appel, GB2
D'Agati, VD2
Sauter, M1
Jülg, B1
Porubsky, S1
Cohen, C1
Fischereder, M1
Sitter, T1
Schlondorff, D1
Gröne, HJ1
Dijkman, HB1
Weening, JJ1
Smeets, B1
Verrijp, KC1
van Kuppevelt, TH1
Assmann, KK1
Steenbergen, EJ1
Wetzels, JF1
Fine, PL1
Fenves, AZ1
Loon, NR1
Jagannath, S1
Kuhn, JA1
Dratch, AD1

Reviews

3 reviews available for pamidronate and Focal Segmental Glomerulosclerosis

ArticleYear
Bisphosphonate nephrotoxicity.
    Kidney international, 2008, Volume: 74, Issue:11

    Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kid

2008
[Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
    Nephrologie & therapeutique, 2009, Volume: 5, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Female; Fractures, Spontaneous

2009
Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
    The American journal of the medical sciences, 2009, Volume: 338, Issue:3

    Topics: Aged; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Gl

2009

Other Studies

7 other studies available for pamidronate and Focal Segmental Glomerulosclerosis

ArticleYear
Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:4

    Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Glomerulosclerosis, Focal S

2011
Podocyte injury associated glomerulopathies induced by pamidronate.
    Kidney international, 2004, Volume: 65, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Biopsy; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis

2004
Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:3

    Topics: Antineoplastic Agents; Basement Membrane; Diphosphonates; Female; Glomerulosclerosis, Focal Segmenta

2004
Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.
    Kidney international, 2006, Volume: 69, Issue:3

    Topics: Acute Kidney Injury; Albumins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Creatinin

2006
Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:6

    Topics: Antineoplastic Agents; Biopsy; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosph

2006
Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells.
    Kidney international, 2006, Volume: 70, Issue:2

    Topics: AIDS-Associated Nephropathy; Antineoplastic Agents; Biomarkers; Biopsy; Cell Division; Diphosphonate

2006
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.
    Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:6

    Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diphosphonates; Female; Glomerulosclerosis, Focal Seg

2001